Perinatal outcomes in type 2 diabetes

Hewapathirana, Niranjala M and Murphy, Helen R (2014) Perinatal outcomes in type 2 diabetes. Current Diabetes Reports, 14. ISSN 1534-4827

Full text not available from this repository. (Request a copy)


Over the past decade the prevalence of type 2 diabetes in pregnancy has continued to increase. It is vital that health care professionals recognize that preconception care is just as important for mothers with type 2 diabetes as it is in type 1 diabetes. All women with type 2 diabetes should be advised regarding safe effective contraception and the benefits of optimal glycemic control, folic acid supplementation, and avoidance of potentially harmful mediations before attempting pregnancy. Glycemic control is the most important modifiable risk factor for congenital anomaly in women with type 2 diabetes, whereas maternal obesity and social disadvantage are associated with large for gestational age neonates. This review aims to bring the reader up to date with the burden of perinatal outcomes and clinical interventions to improve maternal and infant health. It warns that the consequences of type 2 diabetes pregnancy do not end at birth.

Item Type: Article
Uncontrolled Keywords: blood congenital malformation,large for gestational age,macrosomia,perinatal mortality ,stillbirth,neonatal mortality,type 2 diabetes,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User: Pure Connector
Date Deposited: 15 Mar 2016 10:09
Last Modified: 19 Oct 2023 01:39
DOI: 10.1007/s11892-013-0461-1

Actions (login required)

View Item View Item